Natural Product: NPC308381

Natural Product IDNPC308381
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
 DUUKYOAVWFMSKJ-ZVMZQBCWSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0002207] O-glycosyl compounds

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey DUUKYOAVWFMSKJ-ZVMZQBCWSA-N
Standard InCHI InChI=1S/C10H20O9/c11-1-4(14)5(2-12)18-10-9(17)8(16)7(15)6(3-13)19-10/h4-17H,1-3H2/t4-,5+,6-,7-,8+,9+,10-/m1/s1
SMILES C([C@H]([C@H](CO)O[C@H]1[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   284.11 Volume:   252.072
?
Van der Waals volume.
Dense:   1.127 LogP:   -1.823
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -1.362
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
 LogS:   -0.31
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   6.0
TPSA:   160.07
?
Topological Polar Surface Area.
 H-Bond Acceptor:   9.0
H-Bond Donor:   7.0 Rings:   1.0
Heavy Atoms:   9.0

MedChem Properties

QED Drug-Likeness Score:   0.255 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.166 Fsp3:   1.0
MCE-18:   25.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
 Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.056 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.024
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
 Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.489 Promiscuous compounds:   0.054

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.682 MDCK Permeability:   -4.935
Pgp-inhibitor:   0.0 Pgp-substrate:   0.699
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
 Human Intestinal Absorption (HIA):   0.991
20% Bioavailability (F20%):   0.783 30% Bioavailability (F30%):   0.997
50% Bioavailability (F50%):   0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.049 MRP1:   0.065
Plasma Protein Binding (PPB):   30.521% Volume Distribution (VD):   -0.47
Fu: 77.492%
?
The fraction unbound in plasms.
 OATP1B1 inhibitor:   0.997
OATP1B3 inhibitor:   0.999 BCRP inhibitor:   0.01
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.086 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.003
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.098
HLM stability:   0.008
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.841 Half-life (T1/2):  2.152

ADMET: Toxicity

hERG Blockers:  0.003 hERG Blockers (10um):  0.012
Human Hepatotoxicity (H-HT):  0.658 Drug-induced Liver Injury (DILI):  0.418
AMES Toxicity:  0.95 Rat Oral Acute Toxicity:  0.006
Maximum Recommended Daily Dose:  0.002 Skin Sensitization:  1.0
Carcinogencity:  0.319 Eye Corrosion:  0.0
Eye Irritation:  0.268 Respiratory Toxicity:  0.006
Drug-induced Neurotoxicity:  0.035 Ototoxicity:  0.983
Hematotoxicity:  0.7 Drug-induced Nephrotoxicity:  0.678
Genotoxicity:  0.039 RPMI-8226 Immunitoxicity:  0.082
A549 Cytotoxicity:  0.484 Hek293 Cytotoxicity:  0.131
BCF:   0.056
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
 IGC50:   1.071
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   1.99
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
 LC50FM:   1.358
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7019 Hypericum sampsonii Species Hypericaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/j.phytochem.2004.08.014]
NPO7019 Hypericum sampsonii Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[18038963]
NPO3807 Morinda lucida Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[26048790]
NPO12283 Macrothelypteris torresiana Species Thelypteridaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO565 Poria obliqua Species Coccinellidae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO8920 Balanocarpus heimii n.a. n.a. n.a. n.a. n.a. n.a. Database[COCONUT]
NPO7019 Hypericum sampsonii Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO3807 Morinda lucida Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO3807 Morinda lucida Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7019 Hypericum sampsonii Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3807 Morinda lucida Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7019 Hypericum sampsonii Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3807 Morinda lucida Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7019 Hypericum sampsonii Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12283 Macrothelypteris torresiana Species Thelypteridaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3523 Botryllus tyreus Species Styelidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8451 Chilo sacchariphagus Species Crambidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16249 Dendrobium bicameratum Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8920 Balanocarpus heimii n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]
NPO3807 Morinda lucida Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO565 Poria obliqua Species Coccinellidae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC308381 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7778 Intermediate Similarity NPC23134
0.7407 Intermediate Similarity NPC42503
0.7407 Intermediate Similarity NPC282143
0.7407 Intermediate Similarity NPC107914
0.7407 Intermediate Similarity NPC242073
0.7407 Intermediate Similarity NPC299781
0.7407 Intermediate Similarity NPC157193
0.7407 Intermediate Similarity NPC608193
0.6667 Remote Similarity NPC124963
0.6452 Remote Similarity NPC326533
0.625 Remote Similarity NPC317501
0.625 Remote Similarity NPC605930
0.6061 Remote Similarity NPC143326
0.5882 Remote Similarity NPC31496
0.5833 Remote Similarity NPC268243
0.5789 Remote Similarity NPC32148
0.5714 Remote Similarity NPC233726
0.5676 Remote Similarity NPC246558
0.5676 Remote Similarity NPC323361
0.5676 Remote Similarity NPC67660
0.5676 Remote Similarity NPC165198
0.5676 Remote Similarity NPC209753
0.5676 Remote Similarity NPC58629
0.5556 Remote Similarity NPC130683
0.5526 Remote Similarity NPC290179
0.5526 Remote Similarity NPC132938
0.5405 Remote Similarity NPC155457
0.5385 Remote Similarity NPC83248
0.5263 Remote Similarity NPC145112
0.5128 Remote Similarity NPC13143
0.5128 Remote Similarity NPC294813
0.5128 Remote Similarity NPC603514
0.5128 Remote Similarity NPC606861
0.5128 Remote Similarity NPC607126
0.5122 Remote Similarity NPC317023
0.5122 Remote Similarity NPC482639
0.5122 Remote Similarity NPC489878
0.5122 Remote Similarity NPC601741

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC308381 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7097 Intermediate Similarity NPD905 Phase 4
0.6786 Remote Similarity NPD8994 Approved
0.5714 Remote Similarity NPD904 Phase 3
0.5676 Remote Similarity NPD888 Phase 3
0.5676 Remote Similarity NPD889 Approved
0.5676 Remote Similarity NPD890 Clinical (unspecified phase)
0.5676 Remote Similarity NPD891 Phase 3
0.5676 Remote Similarity NPD892 Phase 3
0.5676 Remote Similarity NPD893 Approved
0.5676 Remote Similarity NPD894 Phase 4
0.5556 Remote Similarity NPD887 Approved
0.5556 Remote Similarity NPD895 Phase 4
0.5238 Remote Similarity NPD896 Approved
0.5238 Remote Similarity NPD897 Approved
0.5238 Remote Similarity NPD898 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data